Navigation Links
Nuvo announces second quarter 2008 financial results
Date:7/31/2008

may make a claim of approximately $1.5 million under the Indemnities.

Detailed financial statements and the MD&A are available at http://www.nuvoresearch.com or http://www.sedar.com.

About Pennsaid

Pennsaid(R) is a topical non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis and is currently approved for sale in Canada and several European countries. Pennsaid(R) allows the diclofenac solution to be delivered to a specific site via the surface of the skin and thus limits complications associated with systemic delivery. According to published clinical trials, Pennsaid(R) is as effective as the maximum daily dose of comparable oral medication at relieving pain and stiffness associated with osteoarthritis of the knee, as well as improving overall well-being. There are more than 21 million Americans suffering from osteoarthritis, a very painful and debilitating condition, and the United States market for this condition is estimated at US$4 billion annually. In December 2006, the U.S. Food and Drug Administration issued an approvable letter that indicated Pennsaid(R) is approvable subject to Nuvo satisfying certain conditions.

About Nuvo Research Inc.

Nuvo is a Canadian drug development company primarily focused on the research and development of drug products that are delivered to and through the skin. Nuvo is also involved in research and development activities involving WF10, a chlorite-based, immunomodulating drug through its 60% interest in Dimethaid AG.

Nuvo believes it is uniquely positioned to research and develop new drug product candidates for delivery to and through the skin using its multiplexed molecular penetration enhancers ("MMPE(TM)"s), that interact with the skin and enhance its permeability thereby allowing certain drug molecules to pass into and through the skin to proximate
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
2. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
3. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
4. Hologic Announces Third Quarter Fiscal 2008 Operating Results
5. VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives
6. The Quantum Group Announces 2nd Statewide Contract
7. STERIS Corporation Announces Fiscal 2009 First Quarter Results
8. CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
9. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
10. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
11. Align Technology Announces Second Quarter Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was created ... communities by giving to local charities and causes. ... Holiday, coincides with the kickoff of the holiday shopping ... is to shopping and Cyber Monday is to online ...
(Date:11/28/2014)... Now that the holiday season is here, ... nation's leading cash-for-junk-cars companies, is improving their cash offers ... competitive and help bring a little bit more joy ... year. , Along with purchasing expensive gifts for family ... deal with large travel expenses during the holiday season. ...
(Date:11/28/2014)... 28, 2014 Novatus, a leading ... Release v5.1 which provides customers with greater reporting ... , “As we continue to evolve and ... more functionality and improved performance in response to ... for Novatus. “With the enhancements that we have ...
(Date:11/28/2014)... Wisconsin (PRWEB) November 28, 2014 Dr. ... plastic surgeons , announced the expansion of Quintessa Aesthetic ... center will be located at W307 N1497 Golf Road ... , According to Dr. Campbell, the new Delafield location ... procedures for patients, including: Botox, filler injectables ...
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded cosmetic ... Event for those in the area that would like to learn ... Glow will take place on December 11, 2014, from 6:00 p.m. ... of Houston at 4208 Richmond Ave. , “We want to ... come and celebrate the season with us on December 11, 2014 ...
Breaking Medicine News(10 mins):Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3
... June 20 (HealthDay News) -- The U.S. Food and Drug ... safety and quality of imported drugs and food products. ... increased data sharing, was created in response to rapidly rising ... The strategy is outlined in a special report called the ...
... in the US, the largest of its kind, finds that ... The study, published in the July issue of Pediatrics ... Professor of Pediatrics at Northwestern University Feinberg School of Medicine ... affects 8 percent of children under 18 years of age, ...
... University of Leicester demonstrates that general practitioners (GPs) ... early stages of dementia resulting in both missed ... Researchers from the University of Leicester in ... Health, London, UK and the Department of General ...
... ARBOR, Mich. -- Black patients having a heart attack wait ... that will restore blood flow to their hearts, according to ... differences in care may be explained by hospital quality, rather ... more likely to go to slow hospitals than were whites, ...
... Hamilton, ON (June 20, 20122) - Women with urinary ... to develop postpartum depression as those without incontinence, according ... professor in McMaster University,s School of Nursing. Postpartum ... children in the family. According to the Canadian Mental ...
... June 20, 2011 -- After more than 100 years following ... unknown. To test the validity of present and future proposals ... necessary conditions, are recommended by Jack de la Torre, MD, ... Austin, in an article published in the Journal of ...
Cached Medicine News:Health News:FDA to Step Up Inspections of Imported Products 2Health News:Study shows high prevalence and severity of childhood food allergy in the US 2Health News:GPs missing early dementia -- new study 2Health News:Black heart attack patients wait longer for advanced treatment, University of Michigan study shows 2Health News:Urinary incontinence doubles risk of postpartum depression 2Health News:3 postulates to help identify the cause of Alzheimer's disease 2
(Date:11/28/2014)... Quebec , Nov. 28, 2014  Valeant ... (TSX: VRX) today announced that its wholly owned ... aggregate principal amount of its outstanding 6.875% Senior ... " Notes ") on December 29, 2014 and ... the Notes. Following the redemption, approximately US$500 million ...
(Date:11/28/2014)... The market for both conventional and digital ... in 2014 according to Kalorama Information.  The healthcare market ... incidence of disease are driving the market.  The finding ... X-Ray: World Market Analysis . ... can be obtained at: http://www.kaloramainformation.com/Ray-Digital-8507029/ ...
(Date:11/28/2014)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ... the research, development and commercialization of prescription ophthalmic ... with Deerfield Management and certain of its affiliates ... of preferred stock to Deerfield with an aggregate ... satisfaction of certain closing conditions. Alimera has also ...
Breaking Medicine Technology:Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018 2Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 2Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 3Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3
... in mid 2010, the National Intrepid Center of Excellence ... care of military personnel and veterans suffering from traumatic brain ... ®, an advanced magnetoencephalography (MEG) device, NICoE plans to shed ... , TBI is a leading cause of sustained impairment in ...
... Ariz., Oct. 14 When it comes to slumping ... easy to point a finger at a shrinking sales ... new data from the 2009 Leadership Skills Survey, conducted ... http://www.gottochange.com ), indicates that the root of the ...
Cached Medicine Technology:National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta 2National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta 3Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: